KP Tissue - KPT Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for KP Tissue in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" KPT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KPT, but not buy additional shares or sell existing shares.
View KPT analyst ratings or view top-rated stocks.

3 analysts have issued 12-month price targets for KP Tissue's stock. Their KPT share price forecasts range from C$10.00 to C$10.50. On average, they anticipate the company's share price to reach C$10.20 in the next twelve months. This suggests a possible upside of 1.3% from the stock's current price.
View analysts price targets for KPT or view top-rated stocks among Wall Street analysts.

KP Tissue's stock was trading at C$10.41 at the beginning of 2022. Since then, KPT stock has decreased by 3.3% and is now trading at C$10.07.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 9th 2023.
View our KPT earnings forecast.

KP Tissue announced a quarterly dividend on Wednesday, November 9th. Stockholders of record on Saturday, December 31st will be given a dividend of 0.18 per share on Monday, January 16th. This represents a $0.72 annualized dividend and a dividend yield of 7.15%. The ex-dividend date of this dividend is Thursday, December 29th.
Read our dividend analysis for KPT.

KP Tissue (TSE:KPT) pays an annual dividend of C$0.72 per share and currently has a dividend yield of 7.16%. KPT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 654.55%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for KPT.

Based on aggregate information from My MarketBeat watchlists, some companies that other KP Tissue investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Open Text (OTEX), Rogers Communications (RCI) and Valeant Pharmaceuticals International (VRX).

KP Tissue trades on the Toronto Stock Exchange (TSX) under the ticker symbol "KPT."

Shares of KPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

One share of KPT stock can currently be purchased for approximately C$10.07.

KP Tissue (TSE:KPT) has a market capitalization of C$100.10 million.

KP Tissue's mailing address is 1900 Minnesota Crt Suite 200, MISSISSAUGA, ON L5N 5R5, Canada. The official website for the company is kptissueinc.com. The company can be reached via phone at +1-905-8126900.